RiverPark Funds: "Illumina (ILMN) has Two Large Growth Opportunities Ahead"
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Illumina Inc. (ILMN)
Market is closed
News
- First
- << Previous
- 91 - 100
- Next >>
Is Illumina (ILMN) an Interesting Stock to Buy?
DEVON Equity Management, an investment management firm, published its “Global Opportunities Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Is Illumina (ILMN) A Smart Long-Term Buy?
Ensemble Capital, an investment management firm, published its “Ensemble Fund” second quarter 2021 investor letter – a copy of which can be seen here. A quarterly portfolio net return of 6.93...
5 Stocks Cathie Wood Is Selling
Illumina, Inc. (NASDAQ: ILMN) is a healthcare firm that provides genetic analysis. It is placed fifth on our list of 10 stocks Cathie Wood is selling.
Hedge Funds Are Buying Illumina, Inc. (ILMN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Is It Too Late to Buy Illumina (ILMN) Stock?
Bonsai Partners recently released its Q1 2021 Investor Letter, a copy of which you can download here.
Is Illumina (ILMN) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Is Illumina (ILMN) Stock a Buy For 2021?
Bonsai Partners recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Polen Capital: Illumina (ILMN) Poised to Become 'Even Larger and Stronger' in $20B DNA Sequencing Market
Polen Capital Management, a value-driven, concentrated, long-term investment management firm, published its ‘Polen Focus Growth’ fourth-quarter 2020 Investor Letter – a copy of which can be downloaded...
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
- First
- << Previous
- 91 - 100
- Next >>
Billionaire Hedge Funds
